Young Adults Report ‘Significantly’ Lower Rates Of Alcohol And Tobacco Use Following Marijuana Legalization, Study Finds

November 28, 2023 · marijuanamoment.net

Another federally funded study is suggesting that marijuana legalization may be linked to a “substitution effect,” with young adults in California “significantly” reducing their use of alcohol and cigarettes after the cannabis reform was enacted.

What’s more, the research appeared to contradict prohibitionist arguments about the potential impact of legalization, as the data also revealed no significant increase in marijuana use among young adults who were still not of age to access retail dispensaries—though there were interesting changes in certain modes of consuming cannabis following the policy change.

The study, published in the Journal of Psychoactive Drugs last week, involved surveys of people aged 18-20 living in Los Angeles before and after the state implemented adult-use marijuana legalization under a 2016 voter initiative. One cohort of 172 pre-legalization subjects were interviewed between 2014 and 2015, and the other 139 post-legalization subjects were surveyed between 2019 and 2020.

Researchers said that, “despite the possibilities of increased access to cannabis via diversion from the adult use market and increased normalization of cannabis use,” legalizing recreational marijuana “did not lead to increased frequency of cannabis use” among the subjects. They did notice a shift toward the use of edibles post- adult-use legalization (AUL), however.

“Regarding other licit substance use, we observed significantly fewer days of alcohol and cigarette use among the [post-legalization] cohort compared to the [pre-legalization] cohort,” the study says. This suggests the “possibility of a protective effect offered by cannabis, including edibles, or potentially ongoing changes in norms and attitudes toward these substances within this socio-historical context.”

“Lower frequency of alcohol and tobacco use coupled with increase in edibles use post-AUL may suggest a substitution effect, which could result from increasing access to cannabis through a medical cannabis recommendation or diversion of cannabis from medical or adult use cannabis dispensaries,” the researchers said.

The study, which was funded by the National Institute on Drug Abuse,  also found that changes in the use of illicit and prescription drugs “did not significantly differ” between pre-legalization and post-legalization cohorts, which the researchers said is “notable since some critics predicted that AUL would lead to increased other drug use” via the so-called “gateway theory.”

“Future studies should monitor whether stable rates of cannabis use and declines in alcohol and cigarette use will be sustained as some participants reach legal age to access these substances for adult use, and how these trends continue or alter as participants enter later emerging adulthood,” the study concludes.

While one of the limitations of the study is the fact that people under 21 cannot legally purchase alcohol or tobacco, the findings regarding a possible substitution effect have been echoed in numerous studies covering different jurisdictions across the country, at least when it comes to other substances such as opioids.

For example, legalizing medical marijuana is associated with a “lower frequency” of nonprescribed pharmaceutical opioid use, according to a study published this month in the International Journal of Mental Health and Addiction.

In August, a federally funded study found that marijuana was significantly associated with reduced opioid cravings for people using them without a prescription, suggesting that expanding access to legal cannabis could provide more people with a safer substitute.

A separate study published last month found that legal access to CBD products led to significant reductions in opioid prescriptions, with state-level drops of between 6.6 percent and 8.1 percent fewer prescriptions.

A report from this summer, meanwhile, linked medical marijuana use to lower pain levels and reduced dependence on opioids and other prescription medications. Another, published by the American Medical Association (AMA) in February, found that chronic pain patients who received medical marijuana for longer than a month saw significant reductions in prescribed opioids. (Full Story)

In categories:Legalization Research
Next Post

Arizona Psilocybin Council To Hold First Meeting This Week As Officials Prepare To Distribute $5 Million In Research Grants

An Arizona Psilocybin Research Advisory Council will meet for the first time on Tuesday to start the process of providing millions of dollars in grant funding to support research into the therapeutic potential of psychedelic mushrooms. The council—which was established under…
Read
Previous Post

Swedish Researchers Study Effects of LSD, Ketamine on Rats

Researchers at a university in Sweden are using acid and ketamine to better understand the workings of the brain, which would then lead to the development of artificial intelligence. The researchers, based at Lund University in Lund, Sweden, “have developed…
Read
Random Post

My Dad Was Timothy Leary, 60s Drug Icon

What would you do if Nixon called your father the “the most dangerous man in America”? Tough question – but it’s one of many that stalked Zach Leary, now 49, as he grew up in the shadow of his dad,…
Read
Random Post

UK Prime Minister’s Office: ‘No Plans’ to Reclassify Cannabis from Class B to Class A Drug

The United Kingdom prime minister’s office is distancing itself from a proposal from Conservatives that would reclassify cannabis from a Class B to Class A drug in the country, with a Downing Street spokesperson telling The Guardian that there are “no plans” to…
Read
Random Post

Congress Should Force VA To Study Medical Marijuana For Military Veterans After Years Of Inaction, Lawmaker Says At Hearing

A Democratic congressman says that it’s time for Congress to give the U.S. Department of Veterans Affairs (VA) a mandate to study the benefits and risks of marijuana for military veterans. At a Member Day hearing before the House Veterans’…
Read
Random Post

DEA Defends Firing ‘Outstanding’ Special Agent For Using CBD As An Opioid Alternative

The Justice Department is defending the Drug Enforcement Administration’s (DEA) decision to fire an “outstanding” special agent after 16 years of service because he tested positive for THC after taking a CBD product for pain that he said he believed…
Read